1. Home
  2. WKHS vs SNGX Comparison

WKHS vs SNGX Comparison

Compare WKHS & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$5.38

Market Cap

17.4M

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.35

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
SNGX
Founded
2007
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
14.4M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
WKHS
SNGX
Price
$5.38
$1.35
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$21.00
$6.00
AVG Volume (30 Days)
225.4K
414.6K
Earning Date
11-10-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$92.70
N/A
Revenue Next Year
$34.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.73
N/A
52 Week Low
$5.01
$1.09
52 Week High
$118.50
$6.23

Technical Indicators

Market Signals
Indicator
WKHS
SNGX
Relative Strength Index (RSI) 58.28 44.32
Support Level $5.20 $1.34
Resistance Level $6.00 $1.48
Average True Range (ATR) 0.40 0.09
MACD -0.18 0.01
Stochastic Oscillator 35.35 48.08

Price Performance

Historical Comparison
WKHS
SNGX

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: